ACR Convergence, the world’s premier rheumatology experience, will take place online, November 3 - 9, with extended programming November 10.
Despite a strong desire to return to an in-person format, it is unfortunately not viable this year. As a result, #ACR21 will be offered as an enhanced virtual meeting experience. We hope you’ll join us in November for stellar rheumatology education, outstanding networking opportunities, and more.
Featured #ACR21 Sessions
The Great Debate: Enhancing Lupus Nephritis Therapy: Is Your Next Step Belimumab or Voclosporin?
Track: Systemic lupus erythematosus (SLE)
November 6, 9:00–10:00 AM ET
Speakers: Michelle A. Petri, MD, MPH, and Brad H. Rovin, MD
Recent clinical trials have enriched the treatment landscape of lupus nephritis (LN), and this provides hope for the role of novel agents in managing LN. With trials supporting the use of belimumab and voclosporin in LN, the question remains about which agent to use first. In this year’s Great Debate, Drs. Petri and Rovin will debate this key question: “Enhancing LN therapy – is the next step belimumab or voclosporin?”
The Great Debate: Enhancing Lupus Nephritis Therapy: Is Your Next Step Belimumab or Voclosporin?
ARP Distinguished Lecture: Keeping What You Have and Gaining What You Have Lost: Employment, Poverty and the Rheumatic Diseases
Track: Epidemiology, health policy and outcomes
November 7, 2:00–3:00 PM ET
Speaker: Edward H. Yelin, PhD
Musculoskeletal conditions, particularly autoimmune rheumatic diseases, are among the most common causes of employment problems. These problems include early cessation of work among older individuals and difficulty gaining a toehold in good jobs among younger ones with these conditions. During this session, Dr. Yelin will review specific musculoskeletal conditions that affect employment prevalence, work loss among the employed, and failure to gain access to jobs among the unemployed.
ARP Distinguished Lecture: Keeping What You Have and Gaining What You Have Lost: Employment, Poverty and the Rheumatic Diseases
View the online program and explore opportunities to take a more active role throughout the meeting.
The 2021 accepted abstracts are available on the ACR Convergence Meeting Abstracts website.
See industry engagement (formerly Exhibits) details, including engagement packages, support and advertising opportunities, and more.
Learn more about Community Hubs, an exceptional networking opportunity taking place during ACR Convergence 2021.
See resources, frequently asked questions, and how to get help accessing the virtual meeting platform.
ACR Convergence 2021 Preview
Get ready for ACR Convergence 2021, an all-encompassing virtual experience designed for the global rheumatology community.
We have an action-packed event planned, kicking off on November 1 with early access to the virtual meeting platform, followed by advance programming on November 3 - 5 (including the new Global Rheumatology Summit, Basic and Clinical Research Conference, and Radiology Bootcamp), ACR Convergence scientific programming and special events on November 5 - 9, and the ACR Review Course on November 10.